MicroPort says pooled AMI trial analysis supports aspirin withdrawal after 1-month DAPT post-PCI, cuts major bleeding 52%

• MicroPort announced a European Heart Journal publication of pooled patient-level data on stopping aspirin one month after PCI in heart-attack patients.
• Results were already presented as late-breaking science at the ESC Congress 2026.
• The analysis found early aspirin withdrawal reduced serious bleeding without worsening overall major cardiovascular outcomes versus standard year-long dual therapy.
• Firehawk drug-eluting stents were used in 75% of patients, strengthening the product’s clinical evidence base in a key post-PCI treatment debate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.